Target intelligence / Profile preview

Small nuclear ribonucleoprotein polypeptide B' pseudogene

Molecular classification
Pseudogene, Other
01

Overview

Small nuclear ribonucleoprotein polypeptide B' pseudogene (also known as LOC100421673 or AC022690.1) is a human gene classified as a pseudogene, derived from the SNRPB2 gene family that normally encodes components of the spliceosomal small nuclear ribonucleoproteins (snRNPs)[1][7]. Pseudogenes are DNA sequences that resemble known genes but typically lack the ability to code for a functional protein, often due to mutations or truncations that disrupt normal gene expression. There is no evidence that this pseudogene produces a functional product or serves as a direct target for drugs or therapies. As such, it is not considered a therapeutic target, and most databases classify it only as a pseudogene with no associated biological function, disease role, or drug interaction[1][7]. Note: - If you are seeking information on the functional protein (such as the protein encoded by SNRPB or SNRPB2), refer to those gene entries specifically, as they are the relevant coding genes involved in spliceosomal function and certain autoimmune diseases[3][11]. However, LOC100421673/ENSG00000254425 is not the functional target and should not be used as such.

Other names
AC022690.1LOC100421673Small nuclear ribonucleoprotein polypeptide B2 pseudogeneSNRPB2 pseudogene
02

Biological functions

Other
03

Disease associations

Other

Beyond the preview

Go deeper on Small nuclear ribonucleoprotein polypeptide B' pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Small nuclear ribonucleoprotein polypeptide B' pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call